Stanford University School of Medicine

Rezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress

Wednesday, September 15, 2021 - 9:56pm

Research and development (R&D) expenses were $4.4 million for the fourth quarter of fiscal 2021, compared to $2.4 million for the same period in fiscal 2020.

Key Points: 
  • Research and development (R&D) expenses were $4.4 million for the fourth quarter of fiscal 2021, compared to $2.4 million for the same period in fiscal 2020.
  • Full fiscal year 2021 R&D expenses were $15.0 million, compared to $14.5 million in fiscal year 2020.
  • General and administrative (G&A) expenses were $2.2 million for the fourth quarter of fiscal 2021, compared to $1.1 million for the same period in fiscal 2020.
  • Full fiscal year 2021 G&A expenses were $7.9 million, compared to $6.1 million in fiscal year 2020.

American Skin Association Announces New Board Member Eugene A. Bauer, MD

Wednesday, September 15, 2021 - 4:36pm

NEW YORK, Sept. 15, 2021 /PRNewswire/ -- American Skin Association (ASA) today announced that Eugene Bauer, MD, will join its Board of Directors.

Key Points: 
  • NEW YORK, Sept. 15, 2021 /PRNewswire/ -- American Skin Association (ASA) today announced that Eugene Bauer, MD, will join its Board of Directors.
  • He is immediate past co-founder, Chief Medical Officer, and member of the Board of Directors of Dermira, Inc., a biotechnology company recently acquired by Eli Lilly and Company.
  • "We are proud to announce the addition of Dr. Eugene Bauer to ASA's Board of Directors.
  • Prior to that, he was co-founder and member of the Board of Directors at Connetics, a commercial dermatology company.

Carta Healthcare Celebrates Triple-Digit Growth Among Expanding Partner Base and Leadership Team

Wednesday, September 15, 2021 - 2:00pm

Additionally, experienced industry executives Lucas Tanner and Catherine Mohr have joined Carta Healthcares leadership team and board of directors.

Key Points: 
  • Additionally, experienced industry executives Lucas Tanner and Catherine Mohr have joined Carta Healthcares leadership team and board of directors.
  • Weve experienced remarkable momentum, including the recent addition of three new partners, which brings our partner base to 150 hospitals across 20 health systems, said Matt Hollingsworth, CEO and co-founder of Carta Healthcare.
  • Atlas is Carta Healthcares AI-assisted data abstraction solution for clinical registries, such as The National Cardiovascular Data Registry (NCDR) .
  • Through its industry-leading, AI-driven technology, Carta Healthcare supports the healthcare data registry market by transforming the previously manual clinical data abstraction process.

Gilbert Family Foundation Funds Clinical Study to Understand Vision Loss from NF1 Optic Pathway Glioma

Tuesday, September 14, 2021 - 1:00pm

"One in fiveNF1 patientsdevelopOPGs, and many end up withchronicvision loss,a symptom thatcan have devastating effects on quality of life.We're working to put an effective cure forNF1-OPG-related vision loss and blindness within reach," said Jennifer Gilbert, co-founder of the Gilbert Family Foundation.

Key Points: 
  • "One in fiveNF1 patientsdevelopOPGs, and many end up withchronicvision loss,a symptom thatcan have devastating effects on quality of life.We're working to put an effective cure forNF1-OPG-related vision loss and blindness within reach," said Jennifer Gilbert, co-founder of the Gilbert Family Foundation.
  • Through a combination of established and novel visual function testing methods, this study will define the functional, structural, metabolic and patient-reported components of NF1-OPG-induced vision loss.
  • "As the Vision Restoration Initiative's firstcomprehensivehuman study, this project will provide a newunderstandingofvision loss from NF1-OPGs," says Avery.
  • The Gilbert Family Foundation is a private nonprofit foundation founded by Jennifer and Dan Gilbert to accelerate a cure for neurofibromatosis type 1 (NF1) and build economic opportunity and equity in the city of Detroit.

Water Street Healthcare Partners Appoints Caroline Kenter Larew Vice President

Monday, September 13, 2021 - 12:07pm

CHICAGO, Sept. 13, 2021 /PRNewswire/ -- Water Street Healthcare Partners , a strategic investor focused exclusively on the health care industry, announced today that it has appointed Caroline Kenter Larew vice president.

Key Points: 
  • CHICAGO, Sept. 13, 2021 /PRNewswire/ -- Water Street Healthcare Partners , a strategic investor focused exclusively on the health care industry, announced today that it has appointed Caroline Kenter Larew vice president.
  • Prior to Water Street, Ms. Larew worked as an associate with Madison Dearborn Partners LLC.
  • Water Street has completed more than 100 investments and strategic acquisitions to build 30+ market-leading health care companies in the past decade.
  • Water Street is a strategic investor focused exclusively on health care.

DaVita Announces Dr. Gregory Moore to Join its Board of Directors

Thursday, September 9, 2021 - 9:02pm

announced today that its Board of Directors appointed a new independent director, Gregory Moore, M.D., Ph.D., to join the Board, effective Sept. 9, 2021.

Key Points: 
  • announced today that its Board of Directors appointed a new independent director, Gregory Moore, M.D., Ph.D., to join the Board, effective Sept. 9, 2021.
  • Dr. Moore brings nearly 20 years of health care experience to the Board.
  • Prior to Microsoft, Dr. Moore served as vice president at Google leading Google Cloud Health and Life Sciences globally.
  • With the addition of Dr. Moore, the DaVita Board is composed of nine highly qualified directors, with 33 percent racial/ethnic and 44 percent gender diversity.

Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability

Tuesday, September 7, 2021 - 7:00pm

I Peace launched its clinical-grade personalized iPSC banking service in 2020 in Japan and has already banked several individuals' iPSCs.

Key Points: 
  • I Peace launched its clinical-grade personalized iPSC banking service in 2020 in Japan and has already banked several individuals' iPSCs.
  • Using this as proof of concept, I Peace plans to launch the iPSC banking service in the U.S. as the next phase of its business expansion.
  • I Peace is one of the first companies to develop technology for mass manufacturing iPSCs in a closed system, thus drastically increasing iPSCs manufacturing capability while reducing cost.
  • In March 2020, I Peace developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-sized closed cassette.

Centaur Labs Raises $15 Million, Led by Matrix Partners, to Label the World’s Medical Data, Accelerate AI Development

Friday, September 3, 2021 - 12:00pm

Centaur Labs , a medical data labeling company, today announced $15 million in funding to advance their mission to label the worlds medical data.

Key Points: 
  • Centaur Labs , a medical data labeling company, today announced $15 million in funding to advance their mission to label the worlds medical data.
  • The new capital will fund the expansion of the companys global network of labelers and accelerate product development and hiring.
  • While nearly 30% of the worlds data is generated by the healthcare industry, it is largely unstructured and poorly labeled.
  • To tackle this problem, Centaur has cultivated a network of tens of thousands of medical students and professionals from over 140 countries.

Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary

Wednesday, September 1, 2021 - 1:00pm

We are excited to welcome Preetam and Shane to Cidaras executive team, said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara.

Key Points: 
  • We are excited to welcome Preetam and Shane to Cidaras executive team, said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara.
  • I am confident that Preetams extensive corporate finance and business development experience and Shanes significant corporate law expertise will be tremendous assets to our Company.
  • During this period, he also acted as a consultant for healthcare-focused private equity firms and hedge funds.
  • Cidara is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections.

Visby Medical™ Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test

Monday, August 30, 2021 - 12:00pm

With the capability to detect three of the most common and treatable STIs, the Visby Medical Sexual Health Click Test is uniquely positioned to address women's health needs and promote positive health outcomes.

Key Points: 
  • With the capability to detect three of the most common and treatable STIs, the Visby Medical Sexual Health Click Test is uniquely positioned to address women's health needs and promote positive health outcomes.
  • Use of the Visby device could significantly reduce growing STI rates, especially in communities with limited access to testing.
  • According to Clinical Professor of Medicine, Population and Public Health Sciences, Jeffrey D. Klausner, MD, MPH, University of Southern California, "For both patient care and public health control of these STIs, the Visby Medical Sexual Health Click Test represents a breakthrough.
  • Visby Medical is partnering with government and private entities to accelerate the delivery of PCR-grade diagnostics to the point of care, and eventually for use at home.